Baidu
map

cage略优于自体骨植骨融合

2012-02-03 MedSci MedSci原创

  天津医科大学总医院骨科的一项荟萃分析显示,颈椎椎间融合器(Cage)和自体骨植骨融合治疗颈椎病优良率相同,但cage融合器显著降低术后并发症。该论文发表在《中国脊柱脊髓杂志》[2012,(1):37]。   该研究从7个医学数据库和多本医学期刊纳入关于颈椎前路减压椎间融合器或自体骨植骨融合器治疗颈椎病的RCT研究。经过筛选共11篇符合纳入标准,共1139例患者。   荟萃分析结果显示, c

  天津医科大学总医院骨科的一项荟萃分析显示,颈椎椎间融合器(Cage)和自体骨植骨融合治疗颈椎病优良率相同,但cage融合器显著降低术后并发症。该论文发表在《中国脊柱脊髓杂志》[2012,(1):37]。

  该研究从7个医学数据库和多本医学期刊纳入关于颈椎前路减压椎间融合器或自体骨植骨融合器治疗颈椎病的RCT研究。经过筛选共11篇符合纳入标准,共1139例患者。

  荟萃分析结果显示, cage融合器较自体骨植骨融合平均术中失血量少,平均住院时间短,术后并发症少尤其是取骨处疼痛的发生;但在平均手术时间、融合率、优良率等方面与自体骨植骨融合效果相同。

  相关链接:颈椎前路减压椎间融合器或自体骨植骨融合治疗颈椎病的Meta分析

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1780533, encodeId=0f2d1e80533b6, content=<a href='/topic/show?id=97f839e7d4' target=_blank style='color:#2F92EE;'>#cagE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3977, encryptionId=97f839e7d4, topicName=cagE)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/22AEC2EC4805C29C6E1DEE6D888DB41C/100, createdBy=7a322500193, createdName=ms1779634646866130, createdTime=Wed Aug 15 04:29:00 CST 2012, time=2012-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1821706, encodeId=627d1821e06df, content=<a href='/topic/show?id=db1010184e18' target=_blank style='color:#2F92EE;'>#骨融合#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101847, encryptionId=db1010184e18, topicName=骨融合)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=09a12500213, createdName=12498f1em08(暂无昵称), createdTime=Thu Sep 27 23:29:00 CST 2012, time=2012-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1525345, encodeId=ab1c1525345d1, content=<a href='/topic/show?id=08548885835' target=_blank style='color:#2F92EE;'>#融合#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88858, encryptionId=08548885835, topicName=融合)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08a911636812, createdName=licz0427, createdTime=Sun Feb 05 14:29:00 CST 2012, time=2012-02-05, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1780533, encodeId=0f2d1e80533b6, content=<a href='/topic/show?id=97f839e7d4' target=_blank style='color:#2F92EE;'>#cagE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3977, encryptionId=97f839e7d4, topicName=cagE)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/22AEC2EC4805C29C6E1DEE6D888DB41C/100, createdBy=7a322500193, createdName=ms1779634646866130, createdTime=Wed Aug 15 04:29:00 CST 2012, time=2012-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1821706, encodeId=627d1821e06df, content=<a href='/topic/show?id=db1010184e18' target=_blank style='color:#2F92EE;'>#骨融合#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101847, encryptionId=db1010184e18, topicName=骨融合)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=09a12500213, createdName=12498f1em08(暂无昵称), createdTime=Thu Sep 27 23:29:00 CST 2012, time=2012-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1525345, encodeId=ab1c1525345d1, content=<a href='/topic/show?id=08548885835' target=_blank style='color:#2F92EE;'>#融合#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88858, encryptionId=08548885835, topicName=融合)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08a911636812, createdName=licz0427, createdTime=Sun Feb 05 14:29:00 CST 2012, time=2012-02-05, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1780533, encodeId=0f2d1e80533b6, content=<a href='/topic/show?id=97f839e7d4' target=_blank style='color:#2F92EE;'>#cagE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3977, encryptionId=97f839e7d4, topicName=cagE)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/22AEC2EC4805C29C6E1DEE6D888DB41C/100, createdBy=7a322500193, createdName=ms1779634646866130, createdTime=Wed Aug 15 04:29:00 CST 2012, time=2012-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1821706, encodeId=627d1821e06df, content=<a href='/topic/show?id=db1010184e18' target=_blank style='color:#2F92EE;'>#骨融合#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101847, encryptionId=db1010184e18, topicName=骨融合)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=09a12500213, createdName=12498f1em08(暂无昵称), createdTime=Thu Sep 27 23:29:00 CST 2012, time=2012-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1525345, encodeId=ab1c1525345d1, content=<a href='/topic/show?id=08548885835' target=_blank style='color:#2F92EE;'>#融合#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88858, encryptionId=08548885835, topicName=融合)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08a911636812, createdName=licz0427, createdTime=Sun Feb 05 14:29:00 CST 2012, time=2012-02-05, status=1, ipAttribution=)]
    2012-02-05 licz0427

相关资讯

正确认识和提高荟萃分析(meta分析)质量

 荟萃(Meta)分析是一种统计方法,被用于比较和综合针对同一科学问题所取得的研究结果,得出更可靠的结论。当研究结果存在矛盾而目前又没有能力实施大规模临床研究时,研究者需要采用Meta分析,为决策提供依据,对于已有公认的结论,一般无须进行Meta分析。   Meta分析局限性   理想Meta分析是指纳入所有高质量、同质的研究,无发表偏倚,并采用正确统计方法。然而,由于纳入所有研究十分困难,并

Baidu
map
Baidu
map
Baidu
map